An Integrative Approach to Sarcoidosis and Mixed Connective Tissue Disease - Deanna Windham, DO (2021 Conference) (LDN, low dose naltrexone)

Case Reports of Cancer Therapies - Akbar Khan, MD (2021 Conference) (LDN, low dose naltrexone)

Dr. Khan believes in integrative care, combining allopathic and naturopathic therapies. They treat all types of cancer and people of all ages, with a focus on non-toxic therapy, and quality of life.

Nuts and Bolts of The Thyroid Gland: Therapeutic Targets by Sarah Zielsdorf, MD (2021 Conference) (LDN, low dose naltrexone)

Mast Cell Activation Syndrome (MCAS) - Leonard Weinstock, MD (2021 Conference) (LDN, low dose naltrexone)

Tom O'Bryan, DC - Fire in the Hole: Intestinal Permeability (2017 Conference) (LDN, low dose naltrexone)

Low-dose Naltrexone (LDN) & The Gut Microbiome (LDN) from LDN Research Trust on Vimeo.

Kent MacLeod, RPh., B.Sc., Owner & CEO of NutriChem Compounding Pharmacy & Clinic

Low-dose Naltrexone (LDN) & The Gut Microbiome

Autoimmunity, The Thyroid, Low-dose Naltrexone (LDN) & Beyond (LDN) from LDN Research Trust on Vimeo.

Dr. Yousuf Siddiqui, B.Arch.Sci., N.D

Autoimmunity, The Thyroid, Low-dose Naltrexone (LDN) & Beyond

Low-dose Naltrexone (LDN) & Digestive Conditions (LDN) from LDN Research Trust on Vimeo.

Kim Rovers, NP, MSc., FAAMFM

Low-dose Naltrexone (LDN) & Digestive Conditions

Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders

Int J Pharm Compd
Mar-Apr 2010
https://mail.google.com/mail/u/0?ui=2&ik=b5d7923c33&attid=0.2&permmsgid=msg-f:1668161843235939361&th=1726805badf06421&view=att&disp=safe

Low-dose naltreoxone for the treatment of irritable bowel syndrome: a pilot study

Dig Dis Sci
November 2006
https://pubmed.ncbi.nlm.nih.gov/17080248/